Literature DB >> 16749340

Stroke in Nigerian children with sickle cell disease.

O J Fatunde1, F G Adamson, O Ogunseyinde, O Sodeinde, J B Familusi.   

Abstract

We reviewed our records over a 15-year period to determine whether or not the impression that stroke complicating sickle cell disease was less common than reported in North America. Records of children aged 16 years and below with a diagnosis of stroke seen at the University College Hospital, Ibadan, Nigeria between 1988 and 2002 were examined. Thirty-nine such patients were identified but only 31 had detailed records available for study. Twenty-seven of these had sickle cell disease, 26 with haemoglobin genotype SS and 1 with Hb S+C. Sickle cell disease was therefore responsible for 87% of stroke seen in children at our centre. With an average clinic population of about 500 patients with sickle cell disease, the hospital frequency of stroke among these patients is estimated at 5.4%. The mean age of occurrence of the first stroke was 6.8 years ranging from 17 months to 11 years. Of the 7 patients who had CT scans of the brain done, 5 had evidence of cerebral infarction while 2 had intracerebral haemorrhage. While only 2 deaths occurred among the cases reviewed, morbidity was significant with only 6 patients achieving complete recovery. Recurrent stroke occurred after an average of 25.6 months in 8 of 13 patients who were followed up (61.5%). The incidence of stroke among African children with sickle cell disease appears to be not as high as reported in patients from North America.

Entities:  

Mesh:

Year:  2005        PMID: 16749340

Source DB:  PubMed          Journal:  Afr J Med Med Sci        ISSN: 0309-3913


  11 in total

1.  Antithrombotic therapy in neonates and children: Antithrombotic Therapy and Prevention of Thrombosis, 9th ed: American College of Chest Physicians Evidence-Based Clinical Practice Guidelines.

Authors:  Paul Monagle; Anthony K C Chan; Neil A Goldenberg; Rebecca N Ichord; Janna M Journeycake; Ulrike Nowak-Göttl; Sara K Vesely
Journal:  Chest       Date:  2012-02       Impact factor: 9.410

2.  Stroke Recurrence in Nigerian Children With Sickle Cell Disease: Evidence for a Secondary Stroke Prevention Trial.

Authors:  Shehu U Abdullahi; Michael R DeBaun; Lori C Jordan; Mark Rodeghier; Najibah A Galadanci
Journal:  Pediatr Neurol       Date:  2019-01-17       Impact factor: 3.372

3.  Adverse neurological outcomes in Nigerian children with sickle cell disease.

Authors:  I A Lagunju; B J Brown
Journal:  Int J Hematol       Date:  2012-11-06       Impact factor: 2.490

4.  Stroke Prevalence in Children With Sickle Cell Disease in Sub-Saharan Africa: A Systematic Review and Meta-Analysis.

Authors:  Lianna J Marks; Deogratias Munube; Philip Kasirye; Ezekiel Mupere; Zhezhen Jin; Philip LaRussa; Richard Idro; Nancy S Green
Journal:  Glob Pediatr Health       Date:  2018-05-14

5.  Evaluation of transcranial Doppler abnormalities in children with sickle cell disease in El-Obeid Specialized Children's Hospital.

Authors:  Walaa Ismail Musa Ismail; Mustafa Elnour; Alam Eldin Musa Mustafa
Journal:  J Family Med Prim Care       Date:  2019-03

6.  Primary stroke prevention for sickle cell disease in north-east Italy: the role of ethnic issues in establishing a Transcranial Doppler screening program.

Authors:  Raffaella Colombatti; Giorgio Meneghetti; Mario Ermani; Marta Pierobon; Laura Sainati
Journal:  Ital J Pediatr       Date:  2009-06-22       Impact factor: 2.638

7.  Intellectual function evaluation of first generation immigrant children with sickle cell disease: the role of language and sociodemographic factors.

Authors:  Maria Montanaro; Raffaella Colombatti; Marisa Pugliese; Camilla Migliozzi; Fabiana Zani; Maria Elena Guerzoni; Sheila Manoli; Renzo Manara; Giorgio Meneghetti; Patrizia Rampazzo; Francesca Cavalleri; Marco Giordan; Paolo Paolucci; Giuseppe Basso; Giovanni Palazzi; Laura Sainati
Journal:  Ital J Pediatr       Date:  2013-06-04       Impact factor: 2.638

8.  Pattern of Cerebral Blood Flow Velocity Using Transcranial Doppler Ultrasonography in Children with Sickle Cell Disorder in Lagos State, Nigeria.

Authors:  Motunrayo Oluwabukola Adekunle; Adeola Barakat Animasahun; Ijeoma Nnenna Diaku-Akinwumi; Olisamedua Fidelis Njokanma
Journal:  Mediterr J Hematol Infect Dis       Date:  2017-08-14       Impact factor: 2.576

Review 9.  Neurologic complications of sickle cell disease in Africa: A systematic review and meta-analysis.

Authors:  Jean Jacques Noubiap; Michel K Mengnjo; Nicolas Nicastro; Joseph Kamtchum-Tatuene
Journal:  Neurology       Date:  2017-09-01       Impact factor: 9.910

10.  Comparison of patients from Nigeria and the USA highlights modifiable risk factors for sickle cell anemia complications.

Authors:  Titilola S Akingbola; Bamidele O Tayo; Babatunde Salako; Jennifer E Layden; Lewis L Hsu; Richard S Cooper; Victor R Gordeuk; Santosh L Saraf
Journal:  Hemoglobin       Date:  2014-06-18       Impact factor: 0.849

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.